Completed
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg
NCT04987970
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypertension, +5 more
- Locations
-
- H plus Yangji hospital Seoul, South Korea